KIDS (NASDAQ) - Dividend History and Outstanding Shares

No Dividends discovered - So far (until July 2024) KIDS does not pay dividends. Outstanding Shares evolving.

No Dividends
As of July 2024, Orthopediatrics (KIDS) does not pay a dividend.

Outstanding Shares

What is the Trend of KIDS`s Outstanding Shares?

The Outstanding Shares of Orthopediatrics are growing at a rate of 31.18% per year on average over the last 10 years. The Correlation Coefficent of the Outstanding Shares is 98.60%. Investors should be aware that the price of a stock often is negatively affected by an increasing number of shares.

Did Orthopediatrics ever had a Stock Split?

No Stock Splits found.

Year Number of Shares (Mill.) Growth
2023 23 +9.52%
2022 21 +10.53%
2021 19 +5.56%
2020 18 +20%
2019 15 +15.38%
2018 13 +225%
2017 4 +100%
2016 2
2015 2

Dividend Yields, Growth & Consistency

Overall Dividend Rating -
Dividends Paid 12m - Yield 12m -
Payout Consistency - Yield on Cost 5y -
Growth Rate 5y - Correlation Rate 5y -
First Payout - Next Payout -
Compare KIDS Dividends with its Industry Peers

No Dividends Paid

-

  • KIDS`s 0.00% Dividend Yield is calculated by dividing the dividend payments of the last 12-Months (TTM) of 0.00 by the current stock price 32.60.
  • 0.00% Yield on Cost is the effective dividend income you'd receive today if you purchased the stock five years ago (Rate of the last 12 Months 0.00 divided by the price 5 years ago).
  • The 0.0% Payout Consistency of KIDS Dividends gauges Stability (Values above 80%) or Fragility (Values under 60%).
  • The Average Dividend Growth Rate of 0.00% per year in the last 5-Years showcases KIDS`s commitment to shareholders. Steady or increasing dividends over time can be a sign of a healthy financial outlook.
The Overall Dividend Rating of 0.00 is quantified on a scale from 0 to 100.
Ratings surpassing 50 are regarded as favorable, while those exceeding 75 are exceptionally strong. The calculations includes: Yield, Yield on Cost, Consistency of Payouts and Growth Rates over time.